Physician-Pharmacist Collaboration Keeps Asthma Patients Out of Hospitals

Article

Implementing physician-pharmacist collaborative management methods reduces asthma-related emergency department visits.

In a study that will be presented next month at the American College of Clinical Pharmacy Annual Meeting in Austin, Texas, implementing physician-pharmacist collaborative management (PPCM) methods reduced asthma-related emergency department visits.

Researchers from the University of Iowa College of Pharmacy observed patients enrolled in the Collaboration Among Pharmacists and Physicians to Improve Blood Pressure Now (CAPTION) trial, which aimed to monitor changes in blood pressure levels following the implementation of PPCM. The 5-year CAPTION trial examined 32 primary care clinics, each of which enrolled approximately 10 to 15 patients aged 12 years or older with persistent asthma.

“Asthma in the primary care setting has not received a lot of attention recently with PPCM models,” Tyler Harris Gums, PharmD, corresponding author of the study, told Pharmacy Times in an exclusive interview. “We wanted to explore the pharmacist impact in diseases outside of hypertension and other chronic cardiovascular disease states.”

Among the observed outcomes were the sum of asthma-related emergency department visits and hospitalizations, Asthma Control Test (ACT) scores, Asthma Quality of Life Questionnaire by Marks (AQLQ-M) scores, and asthma medication changes.

Because roughly one-third of the patients had controlled asthma at baseline, additional intention-to-treat analysis was performed to examine the effects of PPCM. The number of emergency department visits and/or hospitalizations decreased by 43.2% during PPCM, but returned to baseline levels once the intervention was terminated.

Following the 9-month PPCM intervention, mean ACT scores increased from the pre-PPCM period. Compared to the post-PPCM period, no significant change was found between the baseline numbers and the post-intervention period, which demonstrated a sustained effect of PPCM, the study authors suggested.

The researchers also noted a significant improvement in AQLQ-M scores during PPCM compared to the pre- and post-intervention periods.

“We were pleasantly surprised by how significant pharmacists were in the care of asthmatics,” Dr. Gums said of the results. “With a large percentage of CAPTION’s patients controlled at baseline, we were concerned any effect would be difficult to see.”

The researchers noted their results align with previous studies focused on PPCM, which similarly proved that the intervention reduces emergency department visits.

“Pharmacists can be a great asset in controlling this chronic disease at the primary care level,” Dr. Gums concluded in the email. “A collaborative team approach has proven worthwhile and, with good execution, can help manage patients’ asthma.”

Related Videos
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
Pharmacist holding medicine box and capsule pack in pharmacy drugstore. -- Image credit: I Viewfinder | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.